BANK OF AMERICA/ US0605051046 /
2024-05-16 6:00:05 PM | Chg. +0.325 | Volume | Bid3:01:03 AM | Ask3:01:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.385EUR | +0.90% | 7 Turnover: 254.695 |
-Bid Size: - | -Ask Size: - | 287.28 bill.EUR | - | - |
GlobeNewswire
05-14
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
05-13
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
05-09
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
GlobeNewswire
05-09
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
05-09
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
GlobeNewswire
05-08
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
GlobeNewswire
05-08
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
GlobeNewswire
05-08
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
GlobeNewswire
05-08
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
GlobeNewswire
05-08
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
GlobeNewswire
05-08
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
GlobeNewswire
05-07
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
GlobeNewswire
05-06
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
GlobeNewswire
05-06
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire
05-06
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference